Drug Type Small molecule drug |
Synonyms 5-methyl-5H-1,2,3,4-tetrahydropyrido[4,3-b]indole |
Target |
Mechanism 5-HT5A receptor modulators(5-hydroxytryptamine receptor 5A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H14N2 |
InChIKeyLSHHYKYAEHDOGB-UHFFFAOYSA-N |
CAS Registry138625-87-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | US | 28 Aug 2003 |